Howard Lightfoot

ORCID: 0000-0003-2082-9986
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Viral-associated cancers and disorders
  • Service and Product Innovation
  • Adipose Tissue and Metabolism
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Biosimilars and Bioanalytical Methods
  • Customer Service Quality and Loyalty
  • Mitochondrial Function and Pathology
  • Lymphoma Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Respiratory viral infections research
  • Cancer Genomics and Diagnostics
  • CRISPR and Genetic Engineering
  • Quality and Supply Management
  • Cancer Cells and Metastasis
  • Bioinformatics and Genomic Networks
  • Renal and related cancers
  • Animal Genetics and Reproduction
  • Gene expression and cancer classification
  • Cancer Research and Treatments
  • Single-cell and spatial transcriptomics
  • DNA Repair Mechanisms
  • Product Development and Customization
  • RNA modifications and cancer
  • Mathematical Biology Tumor Growth

Wellcome Sanger Institute
2016-2025

Advanced Engineering Services (Japan)
2013-2014

Cranfield University
2006-2013

Howard Hughes Medical Institute
2012

Aston University
2011

Alterations in cancer genomes strongly influence clinical responses to treatment and many instances are potent biomarkers for response drugs. The Genomics of Drug Sensitivity Cancer (GDSC) database (www.cancerRxgene.org) is the largest public resource information on drug sensitivity cells molecular markers response. Data freely available without restriction. GDSC currently contains data almost 75 000 experiments, describing 138 anticancer drugs across 700 cell lines. To identify response,...

10.1093/nar/gks1111 article EN cc-by-nc Nucleic Acids Research 2012-11-22

A Product-Service System (PSS) is an integrated combination of products and services. This Western concept embraces a service-led competitive strategy, environmental sustainability, the basis to differentiate from competitors who simply offer lower priced products. paper aims report state-of-the-art PSS research by presenting clinical review literature currently available on this topic. The classified major outcomes each study are addressed analysed. On basis, defines concept, reports its...

10.1243/09544054jem858 article EN Proceedings of the Institution of Mechanical Engineers Part B Journal of Engineering Manufacture 2007-10-01

Systematic studies of cancer genomes have provided unprecedented insights into the molecular nature cancer. Using this information to guide development and application therapies in clinic is challenging. Here, we report how cancer-driven alterations identified 11,289 tumors from 29 tissues (integrating somatic mutations, copy number alterations, DNA methylation, gene expression) can be mapped onto 1,001 molecularly annotated human cell lines correlated with sensitivity 265 drugs. We find...

10.1016/j.cell.2016.06.017 article EN cc-by Cell 2016-07-01

Purpose The purpose of this paper is to report the state‐of‐the‐art servitization by presenting a clinical review literature currently available on topic. aims define concept, its origin, features and drivers give examples adoption along with future research challenges. Design/methodology/approach In determining scope study, focus articles that are central relevant within wider manufacturing context. methodology consists identifying publication databases, searching these using wide range key...

10.1108/17410380910960984 article EN Journal of Manufacturing Technology Management 2009-06-05

Purpose This paper aims to explore practices and technologies successfully servitised manufacturers employ in the delivery of advanced services.

10.1108/ijopm-02-2012-0086 article EN International Journal of Operations & Production Management 2013-12-20

The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-clinical models. We have created a large collection patient-derived tumor xenografts (PDTXs), which the morphological molecular characteristics originating are preserved through passaging mouse. An integrated platform combining vivo maintenance these PDTXs along with short-term cultures PDTX-derived cells (PDTCs) was optimized. Remarkably, genomic clonal architecture present cancers mostly upon...

10.1016/j.cell.2016.08.041 article EN cc-by Cell 2016-09-01

Purpose This paper aims to present a framework that will help manufacturing firms configure their internal production and support operations enable effective efficient delivery of products closely associated services. Design/methodology/approach First, the key definitions literature sources directly with servitization are established. Then, theoretical categorises characteristics manufacturer's strategy is developed this populated using both evidence from extant empirical data. Findings The...

10.1108/01443570910953603 article EN International Journal of Operations & Production Management 2009-04-24

Purpose – The servitization of manufacturing is a diverse and complex field research interest. purpose this paper to provide an integrative organising lens for viewing the various contributions knowledge production from those communities addressing servitization. To achieve this, aims set out address two principal questions, namely where are stocks flows amongst communities? And what generic concerns being addressed by these Design/methodology/approach Using evidenced-based approach, authors...

10.1108/ijopm-07-2010-0196 article EN International Journal of Operations & Production Management 2013-11-11

Abstract Combinations of anti-cancer drugs can overcome resistance and provide new treatments 1,2 . The number possible drug combinations vastly exceeds what could be tested clinically. Efforts to systematically identify active the tissues molecular contexts in which they are most effective accelerate development combination treatments. Here we evaluate potency efficacy 2,025 clinically relevant two-drug combinations, generating a dataset encompassing 125 molecularly characterized breast,...

10.1038/s41586-022-04437-2 article EN cc-by Nature 2022-02-23

Abstract Esophageal adenocarcinoma (EAC) incidence is increasing while 5-year survival rates remain less than 15%. A lack of experimental models has hampered progress. We have generated clinically annotated EAC organoid cultures that recapitulate the morphology, genomic, and transcriptomic landscape primary tumor including point mutations, copy number alterations, mutational signatures. Karyotyping confirmed polyclonality reflecting clonal architecture tumor. Furthermore, subclones underwent...

10.1038/s41467-018-05190-9 article EN cc-by Nature Communications 2018-07-24

Abstract CRISPR-Cas9 viability screens are increasingly performed at a genome-wide scale across large panels of cell lines to identify new therapeutic targets for precision cancer therapy. Integrating the datasets resulting from these studies is necessary adequately represent heterogeneity human cancers and assemble comprehensive map genetic vulnerabilities. Here, we integrated two largest public independent date (at Broad Sanger institutes) by assessing, comparing, selecting methods...

10.1038/s41467-021-21898-7 article EN cc-by Nature Communications 2021-03-12

The proteome provides unique insights into disease biology beyond the genome and transcriptome. A lack of large proteomic datasets has restricted identification new cancer biomarkers. Here, proteomes 949 cell lines across 28 tissue types are analyzed by mass spectrometry. Deploying a workflow to quantify 8,498 proteins, these data capture evidence cell-type post-transcriptional modifications. Integrating multi-omics, drug response, CRISPR-Cas9 gene essentiality screens with deep...

10.1016/j.ccell.2022.06.010 article EN cc-by Cancer Cell 2022-07-14

Genetic screens in cancer cell lines inform gene function and drug discovery. More comprehensive screen datasets with multi-omics data are needed to enhance opportunities functionally map genetic vulnerabilities. Here, we construct a second-generation of dependencies by annotating 930 multi-omic analyze relationships between molecular markers derived from CRISPR-Cas9 screens. We identify dependency-associated expression beyond driver genes, observe many addiction driven gain rather than...

10.1016/j.ccell.2023.12.016 article EN cc-by Cancer Cell 2024-01-11

Purpose The purpose of this study is to examine a buyer's adoption servitization and the associated implications for relationships with its suppliers. Design/methodology/approach authors use case approach tripartite relationship between manufacturing company two paper explores perspectives employees on multiple organisational levels, collects evidence both sides relationship. template analysis utilising Cannon Perreault's connectors framework analyse data. Findings There are overarching...

10.1108/01443571211230916 article EN International Journal of Operations & Production Management 2012-05-12

In vitro cancer cell cultures are facile experimental models used widely for research and drug development. Many lines available efforts ongoing to derive new representing the histopathological molecular diversity of tumours. Cell have been generated by multiple laboratories over decades consequently their annotation is incomplete inconsistent. Furthermore, relationships between many patient-matched derivative lost, accessing information datasets time-consuming difficult. Here, we describe...

10.1093/nar/gky872 article EN cc-by Nucleic Acids Research 2018-09-17

Purpose The debate about services‐led competitive strategies continues to grow, with much interest emerging around the differing practices between production and servitized operations. purpose of this paper is contribute discussion by investigating vertical integration practice (in particular micro‐vertical integration, otherwise known as supply chain position) manufacturers who are successful in their adoption servitization. Design/methodology/approach To achieve authors have investigated a...

10.1108/17410381111160988 article EN Journal of Manufacturing Technology Management 2011-09-11

Purpose – This “research note” sets out to fuel the debate around practices and technologies within operations that are critical success with servitization. It presents a study of four companies which delivering advanced services reports on organisation skill-sets people these. Design/methodology/approach has been case-based research at manufacturers leading in their delivery services. Findings describes desirable behaviour front-line service delivery, identifies supporting skill-sets, how...

10.1108/17410381311327431 article EN Journal of Manufacturing Technology Management 2013-04-29

CRISPR genetic screens in cancer cell models are a powerful tool to elucidate oncogenic mechanisms and identify promising therapeutic targets. The Project Score database (https://score.depmap.sanger.ac.uk/) uses genome-wide CRISPR-Cas9 dropout screening data hundreds of highly annotated genes required for fitness prioritize novel oncology currently allows users investigate the effect 18 009 tested across 323 models. Through interactive interfaces, can by selecting specific gene, model or...

10.1093/nar/gkaa882 article EN cc-by Nucleic Acids Research 2020-10-14

Microsatellite-unstable (MSI) cancers require WRN helicase to resolve replication stress due expanded DNA (TA)n dinucleotide repeats. is a promising synthetic lethal target for MSI tumors, and inhibitors are in development. In this study, we used CRISPR-Cas9 base editing map residues critical cells, validating the domain as primary drug target. Fragment-based screening led development of potent highly selective covalent inhibitors. These compounds selectively suppressed model growth vitro...

10.1158/2159-8290.cd-24-0052 article EN Cancer Discovery 2024-04-06

Abstract Oncology drug combinations can improve therapeutic responses and increase treatment options for patients. The number of possible is vast be context-specific. Systematic screens identify clinically relevant, actionable in defined patient subtypes. We present data 109 anticancer from AstraZeneca's oncology small molecule portfolio screened 755 pan-cancer cell lines. Combinations were a 7 × concentration matrix, with more than 4 million measurements sensitivity, producing an...

10.1158/2159-8290.cd-23-0388 article EN cc-by Cancer Discovery 2024-03-08

Integrated vehicle health management (IVHM) is a collection of data relevant to the present and future performance system its transformation into information can be used support operational decisions. This design operation concept embraces an integration sensors, communication technologies, artificial intelligence provide vehicle-wide abilities diagnose problems recommend solutions. article aims report state-of-the-art IVHM research by presenting systematic review literature. The literature...

10.1243/09544100jaero446 article EN Proceedings of the Institution of Mechanical Engineers Part G Journal of Aerospace Engineering 2008-12-19
Coming Soon ...